Research and Development
Creating products that deliver advanced skin protection requires extensive research and development.
SkinSure are dedicated to making a significant investment in research and development, to create the innovative dermatological treatments that improve the lives of thousands of people. Over the next few years, SkinSure expect to lead the way in the treatment of dry skin conditions, as well as finding a solution to the MRSA and hospital acquired infections around the world.
SkinSure Product Pipeline
Over the next two years SkinSure will be the focus of the following three projects:
- Treatment of Eczema and Atopic Dermatitis
- Treatment of Hand Dermatitis
- Protection from Hospital Acquired Infection
Projects 1 and 2 are already in the second phase of rigorous clinical trials. Project 3 is in its early stages with discussion of preliminary concepts with key health care professionals taking place worldwide.
Clinical Development
Determining the safety and effectiveness of our products is essential.
All clinical research carried out with SkinSure is done in partnership and close liaison with key healthcare professionals, regulatory agencies and Contract Research Organisations (CROs). As a result, clinical programs and trials are designed, planned and conducted in the most stringent, rigorous way. This ensures credibility and quality assurance that international medical research standards, Good Clinical Practice (GCP), and respective regulatory requirements are all adhered to. SkinSure is currently undergoing a number of clinical trials to further research the efficacy and safety of the SkinSure range.
Clinical Trials
Eczema and Atopic Dermatitis Clinical Trial
This clinical trial has been completed and was carried out by the Singapore National Skin Centre. It aimed to evaluate the safety and effectiveness of SkinSure in the treatment of Eczema and Atopic Dermatitis, and the prevention of recurrence. It is now listed on the Australian Register of Therapeutic Goods as a listed medicine and has been presented at the Australasian College of Dermatologist Conference, May 2008 and the American Academy of Dermatologists, March 2009.
Hand Dermatitis Clinical Trial
This clinical trial is being conducted in Solihull Hospital in Birmingham, UK. Its aim is to evaluate the safety and effectiveness of SkinSure in the treatment of hand dermatitis.
Educational Resources
Below, we have included a few links that may be of interest to our visitors.
Skin Conditions
www.eczema.orgThe Eczema Association of Australia.
www.occderm.asn.au
The Occupational Dermatology Research and Education Center.